Breast Cancer Tumor Markers: CA 15-3, CA 27-29, and CEA in Plain Language

If you have seen the names CA 15-3, CA 27-29, or CEA on a lab report, it is natural to feel unsettled. These blood tests measure certain substances in the blood and are sometimes used in breast cancer care — but they do not work the way many people expect. A high number does not by itself mean the cancer has come back, and a normal number does not prove everything is fine. This guide explains, in plain language, what these markers are, what they can and cannot tell you, and how to make sense of your results with your care team.

Key Takeaways

Tumor markers like CA 15-3, CA 27-29, and CEA are substances measured in the blood; some cancers make them, but healthy body processes and benign conditions can raise them too.
These blood tests are not used to screen for breast cancer or to find it early — doctors rely on imaging, exams, and biopsy for diagnosis.
CA 15-3 and CA 27-29 measure very similar things and are usually not ordered together; CEA is a more general marker not specific to breast cancer.
One single result matters far less than the pattern over time — a steady rise or fall across several tests is what doctors pay attention to.
If a marker level is high, it is a signal for your care team to look closer (often with imaging), not a diagnosis of recurrence on its own.
Because every case is different, talk with your own doctor or care team about what your results mean for you.

What Tumor Markers Are

A tumor marker is a substance that can be measured with a lab test — some tumors release these substances, so a higher-than-usual level can sometimes signal that cancer is present or active. The markers used in breast cancer care are measured from an ordinary blood draw; no special preparation is needed.

Tumor markers are not like a pregnancy test, where one result gives a yes-or-no answer — they are clues, not conclusions. A marker level can be elevated when no cancer is present, and perfectly normal even when cancer is there. Diagnosis still comes from imaging and biopsy, as explained in our guide to how breast cancer is found and diagnosed.

Markers are one piece of a larger puzzle, read together with scans, exams, symptoms, and other labs. Your own doctor is the one who can explain what your particular combination means.

CA 15-3, CA 27-29, and CEA in Plain Words

Three marker tests come up most often in breast cancer conversations. Their names are technical, but what they are can be described simply:

Marker	In plain words	When doctors usually order it
CA 15-3 (cancer antigen 15-3)	A protein that some breast cancer cells shed into the bloodstream.	Sometimes to help monitor advanced breast cancer, or to give the team one more data point during treatment.
CA 27-29 (cancer antigen 27-29)	A different fragment of the same protein that CA 15-3 comes from — so it tells essentially the same story.	As an alternative to CA 15-3; doctors typically choose one or the other, not both.
CEA (carcinoembryonic antigen)	A protein that can be made by several types of cancer and by some non-cancer conditions.	Sometimes alongside CA 15-3 or CA 27-29 in advanced breast cancer; it is not specific to breast cancer.

Because CA 15-3 and CA 27-29 measure pieces of the same protein, ordering both adds almost nothing — most doctors pick one and stay with it. CEA is broader, used more often in other cancers, and in breast cancer it is only ever a supporting clue.

You may also hear about newer blood tests that look for tiny pieces of tumor DNA in the bloodstream. Those liquid biopsies are a separate family of tests from the protein markers described here.

A doctor kindly showing a patient a clipboard in a bright, sunlit consultation room, both looking at it together with calm and reassured expressions

What These Blood Tests Can and Cannot Do

It helps to be clear about the limits first, because this is where most anxiety comes from:

They cannot find early breast cancer. Mammograms, ultrasounds, MRIs, and biopsies find cancer; marker blood tests cannot reliably do that job, so they are not used for screening.
They cannot rule cancer out. A normal marker result does not prove that no cancer is present. Some breast cancers simply do not release much of these proteins.
They cannot diagnose a recurrence by themselves. An elevated level is a reason to investigate further, not an answer in itself.
They can help the team watch trends. In advanced breast cancer, marker levels that fall during treatment can be one sign — among many — that treatment is working, and rising levels can prompt the team to take a closer look.
They can prompt useful questions. An unexpected result gives you and your doctor a concrete reason to review symptoms, consider imaging, and double-check the plan.

Think of a marker result as one gauge on a dashboard: your care team reads all the instruments together, not one alone.

Why These Tests Are Not Used for Screening

Many people wonder: if a simple blood test can reflect cancer activity, why isn’t it part of routine screening, like a mammogram? The answer comes down to reliability. For a screening test to be useful, it must catch disease early and not cry wolf too often — and these markers fail on both counts.

First, early breast cancers often produce no detectable rise in these proteins, so a normal result could give false reassurance. Second, many harmless conditions can raise them, so routine testing would send healthy people down a path of scans, worry, and follow-up for nothing. Both problems mean the test would do more harm than good as a screening tool.

The same reasoning explains why doctors generally do not order these markers routinely after early-stage treatment. Regular scans and blood marker checks in people without symptoms have not been shown to change outcomes, while they reliably add anxiety and follow-up testing. Current guidance from major cancer organizations reflects this; if you want to check the latest recommendations yourself, the American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov) publish their patient information there. If your doctor does order a marker test in your situation, they should be able to explain the specific reason — ask them to, in plain words.

Why Results Can Be Confusing

The most common surprise is a high reading in someone who is doing perfectly well. CA 15-3, CA 27-29, and CEA can rise for reasons unrelated to cancer: liver irritation, certain lung or thyroid conditions, inflammation, infection, pregnancy, and smoking (for CEA) can all nudge them up. Your doctor can say which possibilities apply to you.

The second confusion is the opposite one: a normal reading in someone whose cancer is genuinely active. This is simply how the biology works — not every tumor releases these proteins, and some release very little. A normal marker never overrules a concerning scan or symptom.

Different laboratories can use different testing methods that report on different scales, so results from two labs may not be directly comparable. Doctors prefer to follow trends using the same laboratory.

A single elevated number on a screen can feel like terrible news before anyone has explained it. Hold off on conclusions until you have spoken with your care team — your history, your other results, and your past numbers are what turn a raw figure into meaning.

A woman walking peacefully along a sunny park path lined with green trees in soft sunlight

What Happens If a Marker Level Is Elevated

When a marker comes back higher than the lab’s reference range, what usually happens next follows a calm, step-by-step pattern:

The result is repeated. A single reading can be a fluke — a lab variation, a temporary illness, or a benign cause. Doctors often recheck the level before acting on it.
Possible benign causes are reviewed: medications, recent illnesses, and other factors that could explain the rise.
The trend is examined. A small one-time bump means far less than a level that keeps climbing across several tests.
Imaging may be ordered. If the rise is real and unexplained, the next step is usually a scan — such as a CT, bone scan, or PET scan — to look for anything that needs attention. This is the marker doing its actual job: flagging the need for a closer look.
The whole picture is reviewed. Symptoms, exam findings, and other labs are weighed together with the marker and the scan results.

Notice what is missing from that list: an immediate diagnosis or any sudden treatment change. An elevated marker triggers investigation, not verdicts. Many workups end with reassurance — a benign cause found, or a repeat test back in range.

Questions to Ask Your Doctor

If tumor markers have entered your care plan — or if you are wondering why they haven’t — these questions can make the conversation clearer:

Why was this marker test ordered for me, and what question is it meant to answer?
Should I have CA 15-3, CA 27-29, or CEA — and why that one rather than the others?
How will you use the result: is it for monitoring, for investigating something, or for another reason?
What would count as a meaningful change versus normal fluctuation?
Could any of my other conditions or medications affect this result?
Should I have the test done at the same laboratory each time?
If a level comes back high, what would the next step be?
How can I see and keep track of my own results over time?

Keeping your own record of lab results — with dates and the laboratory name — is genuinely useful, especially if you change doctors. Our guide to organizing your scan, lab, and pathology documents has practical ideas for keeping everything in one place.

Frequently Asked Questions

What number is considered “high” for CA 15-3, CA 27-29, or CEA?

Every laboratory sets its own reference range, and different test methods report on different scales — so there is no single universal cutoff. Your report shows the range your lab uses, and your doctor reads your number against your own history, not against an absolute line.

Does a high tumor marker mean my cancer has come back?

No — not by itself. A high marker is a reason to investigate, and many investigations find a benign explanation or a normal repeat result. Recurrence is diagnosed through imaging and sometimes biopsy, with the marker serving as one supporting clue. Talk with your care team about what your specific result means in the context of your history.

Can I ask my doctor to order these tests just for reassurance?

You can — no question is off-limits with your own care team. Just know that doctors may decline if the test is unlikely to give useful information, because an ambiguous result can create worry without a clear next step. If you are anxious about recurrence, say so directly: there may be better ways to address the worry than a test that cannot settle it.

Why did my doctor order CA 15-3 instead of CA 27-29, or the other way around?

They measure fragments of the same protein, so they tell essentially the same story. Doctors usually pick whichever one their laboratory runs most reliably and stick with it, so results stay comparable over time.

Can things like colds, stress, or exercise raise tumor markers?

Infections and inflammation can influence some marker levels, which is one reason doctors often repeat an unexpected result. If you were ill when your blood was drawn, mention it to your doctor. Everyday stress and moderate exercise are not typically the explanation for a large or persistent rise.

Where can I read the official guidance on when these tests should be used?

The American Cancer Society (cancer.org) and the National Cancer Institute (cancer.gov) both publish patient-friendly information about tumor markers. Recommendations can change as evidence grows, so checking the current published guidance is more reliable than anything in a single article.

This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.